Gemcitabine has been proved to interact with immune modulators [23], therefore PD-L1 regulation by the checkpoint inhibitors might be a potential approach to expedite gemcitabine-mediated regulation, on chemotherapy effect and macrophage functions in pancreatic cancer. Here, CD274 is linked to familial pancreatic carcinoma.